Education
About Us
Working with TipRanks
Follow Us
FALCO HOLDINGS Co., Ltd (JP:4671)
:4671
RESEARCH TOOLSreports
Top Page
FALCO HOLDINGS Co., Ltd
(4671)
58Neutral
FALCO HOLDINGS Co., Ltd (4671) vs. S&P 500 (SPY)
Market Cap
¥23.21B
Dividend Yield5.34%
Average Volume (3M)16.04K
Price to Earnings (P/E)13.9
Beta (1Y)0.56
Revenue Growth0.16%
EPS Growth-10.08%
CountryJP
Employees1,117
SectorHealthcare
Sector Strength69
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)165.45
Shares Outstanding10,880,177
10 Day Avg. Volume12,310
30 Day Avg. Volume16,040
Financial Highlights & Ratios
PEG Ratio3.71
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FALCO HOLDINGS Co., Ltd Business Overview & Revenue Model
Company DescriptionFALCO HOLDINGS Co., Ltd (4671) is a Japanese company that operates primarily in the healthcare and medical sectors. The company provides a range of services including clinical testing, pharmaceutical development, and medical information services. FALCO HOLDINGS is known for its commitment to advancing healthcare through innovative technologies and comprehensive solutions that cater to hospitals, clinics, and research institutions.
How the Company Makes MoneyFALCO HOLDINGS Co., Ltd generates revenue primarily through its clinical testing services, which cater to healthcare providers by offering diagnostic testing and analysis. Additionally, the company earns income from its pharmaceutical development services, which include contract research and development for pharmaceutical companies. The company's medical information services also contribute to its revenue by providing critical data and insights to healthcare professionals. Strategic partnerships with healthcare institutions and research organizations further enhance its revenue streams by expanding its service offerings and market reach.
FALCO HOLDINGS Co., Ltd Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 43.09B | 43.01B | 46.91B | 50.01B | 43.61B | 43.19B | Gross Profit |
| 13.03B | 12.92B | 14.64B | 17.32B | 13.70B | 12.34B | EBIT |
| 2.28B | 2.15B | 3.08B | 5.50B | 2.61B | 348.00M | EBITDA |
| 3.04B | 3.56B | 4.12B | 6.46B | 3.57B | 1.77B | Net Income Common Stockholders |
| 1.80B | 1.67B | 2.26B | 3.53B | 1.85B | 1.24B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 7.67B | 10.06B | 12.60B | 10.64B | 11.62B | 7.27B | Total Assets |
| 32.37B | 36.42B | 38.89B | 40.26B | 37.07B | 31.96B | Total Debt |
| 2.39B | 817.00M | 2.80B | 4.07B | 5.90B | 3.51B | Net Debt |
| -5.28B | -9.25B | -9.80B | -6.58B | -5.71B | -3.76B | Total Liabilities |
| 13.28B | 10.40B | 12.30B | 16.78B | 16.59B | 13.06B | Stockholders Equity |
| 19.10B | 26.03B | 26.59B | 23.48B | 20.48B | 18.89B |
| Cash Flow | Free Cash Flow | ||||
| 976.00M | 2.19B | 708.00M | 1.94B | 1.32B | 787.00M | Operating Cash Flow |
| 976.00M | 3.43B | 2.09B | 4.13B | 2.94B | 1.90B | Investing Cash Flow |
| 0.00 | -1.45B | 322.00M | -2.69B | -52.00M | -1.19B | Financing Cash Flow |
| 0.00 | -4.53B | -448.00M | -2.41B | 1.46B | -1.27B |
FALCO HOLDINGS Co., Ltd Technical Analysis
Positive
2314.00
Price Trends
2303.83
Positive
2289.63
Positive
2282.11
Positive
Market Momentum
-0.13
Negative
54.41
Neutral
76.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4671, the sentiment is Positive. The current price of 2314 is above the 20-day moving average (MA) of 2254.60, above the 50-day MA of 2303.83, and above the 200-day MA of 2282.11, indicating a bullish trend. The MACD of -0.13 indicates Negative momentum. The RSI at 54.41 is Neutral, neither overbought nor oversold. The STOCH value of 76.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4671.
FALCO HOLDINGS Co., Ltd Peers Comparison
Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $760.83B | 10.49 | 9.06% | 4.39% | -2.16% | -40.39% | |
75 Outperform | $1.66T | 28.76 | 13.12% | 1.15% | 14.50% | 29.02% | |
74 Outperform | $1.09T | 18.44 | 6.95% | 2.55% | 12.06% | -25.28% | |
67 Neutral | ¥113.89B | 18.95 | 3.36% | 11.54% | -8.30% | ||
58 Neutral | ¥23.21B | 13.91 | 5.34% | 0.16% | -10.08% | ||
51 Neutral | $5.32B | 3.39 | -40.26% | 2.89% | 17.93% | 2.48% | |
48 Neutral | $154.95B | ― | -1.07% | 4.89% | 1.70% | 78.07% |
* Healthcare Sector Average
Performance Comparison
JP:4671
FALCO HOLDINGS Co., Ltd
2,314.00
203.27
9.63%
JP:7730
Mani, Inc.
1,156.00
-631.96
-35.35%
JP:6869
Sysmex
2,660.50
153.81
6.14%
JP:4151
Kyowa Kirin Co
2,199.00
-390.47
-15.08%
JP:4528
ONO Pharmaceutical Co
1,620.00
-557.54
-25.60%
JP:4544
HUGroup Holdings
2,714.50
418.39
18.22%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.